These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8174491)

  • 1. A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs.
    Leemann TD; Transon C; Bonnabry P; Dayer P
    Drugs Exp Clin Res; 1993; 19(5):189-95. PubMed ID: 8174491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The biotransformation of NSAIDs: a common elimination site and drug interactions].
    Leemann T; Kondo M; Zhao J; Transon C; Bonnabry P; Dayer P
    Schweiz Med Wochenschr; 1992 Dec; 122(49):1897-9. PubMed ID: 1462152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver.
    Leemann T; Transon C; Dayer P
    Life Sci; 1993; 52(1):29-34. PubMed ID: 8417277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro oxidation of oxicam NSAIDS by a human liver cytochrome P450.
    Zhao J; Leemann T; Dayer P
    Life Sci; 1992; 51(8):575-81. PubMed ID: 1640808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel bioactivation pathway for 2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoic acid (diclofenac) initiated by cytochrome P450-mediated oxidative decarboxylation.
    Grillo MP; Ma J; Teffera Y; Waldon DJ
    Drug Metab Dispos; 2008 Sep; 36(9):1740-4. PubMed ID: 18541695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
    Huskey SW; Dean DC; Miller RR; Rasmusson GH; Chiu SH
    Drug Metab Dispos; 1995 Oct; 23(10):1126-35. PubMed ID: 8654202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
    Franklin MR; Hathaway LB
    Drug Metab Dispos; 2008 Dec; 36(12):2539-46. PubMed ID: 18799803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro biotransformation and identification of human cytochrome P450 isozyme-dependent metabolism of tazofelone.
    Surapaneni SS; Clay MP; Spangle LA; Paschal JW; Lindstrom TD
    Drug Metab Dispos; 1997 Dec; 25(12):1383-8. PubMed ID: 9394028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of major drug metabolizing cytochrome P450 isozymes in human liver microsomes by carbon monoxide.
    Leemann T; Bonnabry P; Dayer P
    Life Sci; 1994; 54(14):951-6. PubMed ID: 8139385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of aceclofenac in humans.
    Bort R; Ponsoda X; Carrasco E; Gómez-Lechón MJ; Castell JV
    Drug Metab Dispos; 1996 Aug; 24(8):834-41. PubMed ID: 8869816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
    Shen S; Marchick MR; Davis MR; Doss GA; Pohl LR
    Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
    Raner GM; Vaz AD; Coon MJ
    Mol Pharmacol; 1996 Mar; 49(3):515-22. PubMed ID: 8643091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.
    Rodrigues AD; Kukulka MJ; Roberts EM; Ouellet D; Rodgers TR
    Drug Metab Dispos; 1996 Jan; 24(1):126-36. PubMed ID: 8825200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of new sulfaphenazole derivatives with human liver cytochrome p450 2Cs: structural determinants required for selective recognition by CYP 2C9 and for inhibition of human CYP 2Cs.
    Ha-Duong NT; Marques-Soares C; Dijols S; Sari MA; Dansette PM; Mansuy D
    Arch Biochem Biophys; 2001 Oct; 394(2):189-200. PubMed ID: 11594733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
    Teiber JF; Hollenberg PF
    Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
    Chulada PC; Langenbach R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions.
    Karjalainen MJ; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):157-65. PubMed ID: 18816299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.